Locations:
Search IconSearch
March 7, 2024/News Releases

Registration Open for VeloSano Bike to Cure 2024

100% of funds raised by participants support cancer research at Cleveland Clinic

On-Course-Main-Campus

VeloSano Bike to Cure will take place Sept. 6-7, 2024. VeloSano is a fundraising movement created to enable the cancer treatments of today and the cures of tomorrow through innovative, transformative research happening at Cleveland Clinic locations around the world.

Registration is now open for Bike to Cure, the annual flagship fundraising event in which 100% of dollars raised by participants support lifesaving cancer research at Cleveland Clinic and Cleveland Clinic Children’s. The public can register to participate at velosano.org

Bike to Cure weekend will include a kickoff party on Friday, Sept. 6, that will bring riders and supporters together to support “Living Hope” cancer survivors and patients, honor legacies and cheer the progress being made in cancer research at Cleveland Clinic. Food, beverages and music will be offered on Mall B in downtown Cleveland. 

Saturday, Sept. 7, is ride day. Available route distances are 12, 25, 50, 75 and 100 miles, as well as the Guardians City Loop Ride, a one-lap, six-mile loop around downtown Cleveland. Ideal for families and beginner riders, the Guardians City Loop highlights city landmarks including a lap around Progressive Field. Those who register as virtual fundraisers can choose their own activity and participate in any way, anytime, and anywhere to fundraise for cancer research at Cleveland Clinic. 

Since its inception in 2014, more than $51 million has been raised for cancer research at Cleveland Clinic. Dollars from founding partners, including the Kohl Fund and the Cleveland Guardians, support VeloSano signature events and sustain year-round fundraising operations.

Learn more about cancer research funded by VeloSano by visiting impact.velosano.org. Volunteer registration will open at a later date.

About Cleveland Clinic

Cleveland Clinic is a nonprofit multispecialty academic medical center that integrates clinical and hospital care with research and education. Founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation, Cleveland Clinic has pioneered many medical breakthroughs, including coronary artery bypass surgery and the first face transplant in the United States. Cleveland Clinic is consistently recognized in the U.S. and throughout the world for its expertise and care. Among Cleveland Clinic’s 83,000 employees worldwide are more than 6,600 salaried physicians and researchers, and 21,900 registered nurses and advanced practice providers, representing 140 medical specialties and subspecialties. Cleveland Clinic is a 6,725-bed health system that includes a 173-acre main campus near downtown Cleveland, 23 hospitals, 300 outpatient facilities, including locations in northeast Ohio; Florida; Las Vegas, Nevada; Toronto, Canada; Abu Dhabi, UAE; and London, England. In 2025, there were 15.9 million outpatient encounters, 343,000 hospital admissions and observations, and 336,000 surgeries and procedures throughout Cleveland Clinic’s health system. Visit us at clevelandclinic.org. Follow us at x.com/CleClinicNews. News and resources are available at newsroom.clevelandclinic.org.

Editor’s Note: Cleveland Clinic News Service is available to provide broadcast-quality interviews and B-roll upon request.

Latest from the Newsroom

Photo of prescription pills and pill bottles

University Hospitals and Cleveland Clinic to Host National Prescription Drug Take Back Day

Logos of Cleveland Clinic and the Women’s Alzheimer’s Movement (WAM) at Cleveland Clinic

Leading Researchers and Advocates Honored by Maria Shriver and The Women’s Alzheimer’s Movement at Cleveland Clinic

Beri Ridgeway, M.D.

Cleveland Clinic Appoints Beri Ridgeway, M.D., as President of Cleveland Clinic London

Genediting Therapy Shows Success Against Severe Sickle Cell Disease

Gene Editing Therapy Shows Success Against Severe Sickle Cell Disease

Cleveland Clinic's Main Campus lobby

Mandel Foundation Donates $50 Million to Improve Access to Care at Cleveland Clinic

Blood pressure cuff

Experimental Monthly Injectable Reduces a Key Regulator of Blood Pressure

GLP-1 injection pen with a stethoscope

Tirzepatide Associated with Lower Risk of Heart and Kidney Damage Compared to Dulaglutide in Patients with Type 2 Diabetes and Cardiovascular Disease

Hospital Care At Home

Cleveland Clinic Introduces Hospital Care At Home in Ohio